Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Osteobriks Tablets (commonly marketed as Osteobrix) is a nutritional supplement developed by Stevia Pharmaceuticals, an Indian pharmaceutical company. The product is formulated to support bone health and address calcium deficiency. It typically contains a combination of calcium citrate and elemental magnesium. Calcium citrate is utilized for its high bioavailability in providing elemental calcium, which is a primary structural component of bone tissue and is necessary for various physiological processes including muscle contraction and nerve signaling. Magnesium is included to facilitate calcium absorption and serve as a cofactor for enzymes involved in bone formation and the regulation of calcium homeostasis. The product is approved and marketed in India for individuals requiring mineral supplementation to prevent or treat conditions like osteoporosis and hypocalcemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Osteobrix Tablets.